A blocking peptide containing 14 amino acids near the carboxy terminus of human cIAP1.
Points forts
Source
Synthetic
(Accession #: NP_001157) The cIAP-1/HIAP-2 Blocking Peptide has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-050698 |
|---|
| Réf. fabricant | 18228995 |
|---|
| Gene ID (Entrez) | 329 |
|---|
| Espèces | Human |
|---|
| Numéro d’adhésion | Q13490 |
|---|
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
|---|
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-77193. For Further Blocking Peptide Related Protocol, Click Here . |
|---|
| Alias de gène | API1Hiap-2, apoptosis inhibitor 1, baculoviral IAP repeat containing 2, baculoviral IAP repeat-containing 2, baculoviral IAP repeat-containing protein 2, cIAP1, C-IAP1, hIAP2, hIAP-2, IAP homolog B, IAP2, IAP-2, Inhibitor of apoptosis protein 2, MIHBHIAP2, NFR2-TRAF signalling complex protein, RING finger protein 48, RNF48hiap-2, TNFR2-TRAF-signaling complex protein 2 |
|---|
| Symbole de gène(s) | BIRC2 |
|---|
| Type de produit | cIAP-1/HIAP-2 |
|---|
| Quantité | 0.05 mg |
|---|
| État réglementaire | RUO - research use only |
|---|
| Source | Synthetic |
|---|
| Consigne | 14 amino acids near the carboxy terminus of human cIAP1 |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
